Position in IQV
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$3,091
+$3,087 QoQ
Shares Held
16
-40.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,011
of 1,077 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IQV Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026OGOREK ANTHONY JOSEPH /NY/ /ADV holds $165,723 across 9 Diagnostics & Research names. IQV ranks #7 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
348 | $66,287 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
70 | $35,095 | |
| 3 | LH |
Labcorp Holdings Inc.
|
82 | $22,960 | |
| 4 | DGX |
Quest Diagnostics Inc
|
84 | $17,803 | |
| 5 | WAT |
Waters Corp /De/
|
28 | $10,501 | |
| 6 | ILMN |
Illumina, Inc.
|
52 | $9,143 | |
| 7 | IQV |
Iqvia Holdings Inc.
This page
|
16 | $3,091 | |
| 8 | RVTY |
Revvity, Inc.
|
4 | $445 |
All Filings in IQV
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,091 | 16 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $4 | 27 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $6,311 | 28 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $8,357 | 44 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $2 | 16 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $4 | 28 | Shares | Sole | 2025-05-09 | |
| No filing history on record for this holder in this stock. | ||||||